MRI Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri.

Next Previous
Trial Profile

MRI Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use

    • Most Recent Events

    • 09 Nov 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 11 Apr 2012 Actual patient number 8 added as reported by ClinicalTrials.gov.
    • 11 Apr 2012 Actual end date Mar 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top